Open Access
CC BY-NC-ND 4.0 · Laryngorhinootologie 2018; 97(S 02): S158
DOI: 10.1055/s-0038-1640256
Poster
Otologie: Otology

The cannabinoid receptor 2 agonist JWH-133 is capable of revoking changes in cochlear microcirculation induced by lipopolysaccharide

M Bertlich
1   Klinik für Hals-, Nasen, Ohrenheilkunde, LMU München, München
,
BG Weiss
1   Klinik für Hals-, Nasen, Ohrenheilkunde, LMU München, München
,
M Jakob
1   Klinik für Hals-, Nasen, Ohrenheilkunde, LMU München, München
,
M Canis
1   Klinik für Hals-, Nasen, Ohrenheilkunde, LMU München, München
,
F Ihler
1   Klinik für Hals-, Nasen, Ohrenheilkunde, LMU München, München
› Institutsangaben
 
 

    Introduction:

    Cannabinoid receptors (CBR) are divided into two subclasses. The subtype 2 mediates several antiinflammatory effects that make it a valid candidate as an otoprotective agent. We therefore investigated the ability of JWH-133, a CBR-2 agonist, to reduce the effects of abacterial labyrinthitis on cochlear microcirculation.

    Material and Methods:

    40 dunkin-hartley guines pigs were divided into 8 groups of 5 animals each. In each animal cochlear microcirculation was quantified by in-vivo fluorescence microscopy. In the first four groups, lipopolysaccharide (LPS) was applied topically in various concentration (1 mg/ml, 10 µg/ml, 100 ng/ml, placebo) to emulate the effects of abacterial labyrinthitis. In the second four groups, JWH-133 (500 ng/ml), a potent CBR-2 agonist, was applied topically before application of LPS. Microcirculation was quantified before, 30 minutes after the initial treatment and at the end of the second treatment.

    Results:

    30 and 60 minutes after topical application of LPS, microcirculation dropped to 79.1% or 75.6%, respectively (1 mg/ml), to 88.8% or 81.7%, respectively (10 µg/ml) and to 96.8% or 89.3%, respectively (100 ng/ml). Application of Placebo caused no such decreases in microcirculation (99.8% and 99.6% from the basal values). Previous application of JWH-133 showed no changes in microcirculation (97.8% of the basal values). The subsequent application of LPS then caused no changes in microcirculation (99.0% of the basal values).

    Conclusion:

    JWH-133 is capable of abrogating the effects of abacterial labyrinthitis on cochlear microcirculation. It therefore is a valid candidate as an otoprotective agent in bacterial otitis media and various other inner ear pathologies.


    No conflict of interest has been declared by the author(s).

    Dr. med. Mattis Bertlich
    Klinik für Hals-, Nasen, Ohrenheilkunde, LMU München,
    Marchioninistr. 15, 81377,
    München

    Publikationsverlauf

    Publikationsdatum:
    18. April 2018 (online)

    © 2018. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).

    Georg Thieme Verlag KG
    Stuttgart · New York